Globus Medical GMED
Valuation
Multiples measured against the stock's own five-year history
Near the bottom of its 5-year range · 1st percentile, 5-year average 63.6x
#1431 of 2994 stocks by PE (1 = cheapest)
Near the bottom of its 5-year range · 19th percentile, 5-year average 2.8x
#3073 of 5331 stocks by PB (1 = cheapest)
Near the bottom of its 5-year range · 4th percentile, 5-year average 5.1x
#3188 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 1.99 | – | 2.80 | 19% (cheaper than usual) | #3073 of 5331 (1 = cheapest) |
| PE | 17.77 | 16.00 | 63.63 | 1% (cheaper than usual) | #1431 of 2994 (1 = cheapest) |
| PS | 3.04 | 3.00 | 5.07 | 4% (cheaper than usual) | #3188 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on GMED.
Sign in to join the discussion.